No Data
No Data
Gyre Therapeutics | 10-Q: Quarterly report
Gyre Therapeutics Reports First Quarter 2024 Earnings
Express News | Gyre Therapeutics Inc: Qtrly Diluted Shr $0.03
Express News | Gyre Therapeutics Inc: Anticipates That Its Cash Resources as of March 31 Will Enable It to Fund Operations Through at Least 12 Months
Express News | Gyre Therapeutics Inc: U.S. Ind Submission to Evaluate F351 for Treatment of Nash-Associated Liver Fibrosis Expected in Late 2024
Express News | Gyre Therapeutics Q1 Operating Profit USD 8.1 Million
No Data
BelleWeather : GILD is down .03%, or two cents. Two pennies. That is not a remarkable fall.
71731595 BelleWeather: Remarkable
DudeThatsDerpy : Sheesh. The spelling errors in this article make it feel less reliable.